TITLE:
Review Venous Thromboembolism Risk with Anti-Osteoporosis Drugs
AUTHORS:
Kawtar Nassar, Wafae Rachidi, Saadia Janani, Ouafa Mkinsi
KEYWORDS:
Osteoporosis, Venous Thrombosis, Drugs, Estrogens, Progestins
JOURNAL NAME:
Open Journal of Rheumatology and Autoimmune Diseases,
Vol.8 No.4,
October
30,
2018
ABSTRACT: Osteoporosis is the most common skeletal diseases, predisposing the patient
to an increased risk of fractures. It is an important health issue linked to increased
morbidity and mortality. Prevention and treatment strategies are now
well defined and are always updating. Indeed, the therapeutic decision is
based on the individual risk of fracture, efficiency and degree of therapeutic
tolerance. However, some side effects, although rare can be attributed to
drugs used. The benefit and risks of prescription drugs can be optimized by
choosing the right time and the right treatment. The purpose of this article is
the study of thromboembolic risk of various drugs recommended in osteoporosis.
Furthermore we discuss preventive measures, and the different approaches
after the first event.